Mailed FIT-DNA Kits Significantly Increase Colorectal Cancer Screening in Underserved U.S. Communities

Mailed FIT-DNA kits significantly boost colorectal cancer screening in community health centers, yet follow-up colonoscopy rates remain below 40%.

By: AXL Media

Published: Apr 30, 2026, 4:57 AM EDT

Source: Information for this report was sourced from News Medical Life Sciences and JAMA Internal Medicine

Innovative Outreach Enhances Participation in Cancer Prevention

A new study published in JAMA Internal Medicine on April 30, 2026, indicates that mailed fecal immunochemical test-DNA (FIT-DNA) kits represent a superior outreach strategy for increasing colorectal cancer (CRC) screening. Conducted across eight community health centers in Boston and Los Angeles, the trial involved 5,127 adults aged 45 to 75 who were overdue for screening. The results demonstrated that participants who received FIT-DNA kits with manufacturer-supported outreach protocols had significantly higher participation rates within 90 and 180 days compared to those assigned to traditional fecal immunochemical tests (FIT). This shift suggests that leveraging manufacturer-led support systems can reduce the administrative burden on primary care staff while simultaneously improving patient engagement in at-risk populations.

Sensitivity and Support Programs Drive Higher Completion Rates

The enhanced effectiveness of the FIT-DNA approach is largely attributed to the structured outreach provided by the kit manufacturers. Unlike the standard FIT kits, which often rely on automated text reminders from clinic personnel, the FIT-DNA program includes a comprehensive patient assistance protocol. Researchers noted that the higher sensitivity of the DNA-based test and the convenience of a three-year screening interval may have further motivated patients in underprivileged settings. Colorectal cancer remains the second leading cause of cancer-related deaths in the United States, and these findings highlight a viable path toward closing the screening gap for populations that traditionally face significant barriers to preventative healthcare.

Follow-Up Colonoscopy Rates Remain a Critical Healthcare Bottleneck

Despite the success in initial screening uptake, the study identified a concerning gap in the continuum of care. Among participants who received abnormal test results, only 36 out of 100 completed a follow-up colonoscopy within the recommended 180-day window. This suboptimal follow-up rate persisted despite the provision of standardized navigation support intended to facilitate hospital visits. The findings underscore a major challenge in colorectal cancer prognosis: while home-based kits can identify potential issues, the transition to clinical diagnostic procedures remains hindered by socioecono...